Dan Seifert / The Verge
Samsung got US FDA clearance for its electrocardiogram (EKG) monitoring app in August, but today the functionality is finally rolling out to the company’s latest smartwatch, the Galaxy Watch 3, as well as the Galaxy Active 2 from late 2019.
Previously limited to South Korea, the app now lets users in the US monitor their heart rhythm for irregularities and check for atrial fibrillation (Afib). You’ll be able to use it yourself in the “ECG Monitor” app, where Samsung says readings will be accessible through the Health Monitor app when your watch is connected to a Samsung Galaxy-branded phone. Samsung notes that it’s not intended for use by people under 22 years old.
To take a…tech, The Verge